CD8A and acute myeloid leukemia: As discussed previously, numerous AML patient studies have identified an augmented population of Tregs, diminished helper T cell function, reduced IFN-γ secretion, and a significantly increased frequency of terminally differentiated or exhausted CD8+ T cells compared with healthy controls [23,24,44].